Miro Sciences Ltd

MSX · AU · Healthcare / Biotechnology

0.042AUD+0.00 (+2.44%)

Price History

Full chart

Market Stats

Previous Close0.041

Open0.043

Day Range0.042 – 0.043

52-Week Range0.041 – 0.059

Volume14.60K

Market Cap19.49M

P/E (TTM)0.00

Forward P/E0.00

EPS-0.01

Dividend Yield0.00%

Beta1.23

50-Day Avg0.0569

200-Day Avg0.0569

About

Miro Sciences Ltd engages in the research and development of biomedical products targeting neurodegenerative conditions and immune-mediated inflammatory diseases. Its lead product is the EmtinB drug for the treatment of optic nerve diseases, such as glaucoma. The company also develops StemSmart platform technology to treat inflammatory immune disorders. Miro Sciences Ltd was formerly known NeuroScientific Biopharmaceuticals Limited and change its name to Miro Sciences Ltd in October 2026. The company was incorporated in 2002 and is based in Perth, Australia.

Company Details

SectorHealthcare
IndustryBiotechnology
CEOMr. Nathan Smith
HeadquartersLevel 4, Perth, WA, Australia, 6000, Australia
Websitehttps://www.neuroscientific.com

Leadership

Mr. Nathan SmithChief Executive Officer
Dr. Marian SturmChief Scientific Officer
Dr. Catherine Cole MBBSChief Medical Officer

Financials

Income Statement

Currency: AUD	2023-06-30	2024-06-30	2025-06-30	2026-06-30
Operating Income	-6.12M	-2.06M	-2.01M	-5.11M
EBITDA	-1.01M	425.54K	-1.75M	-3.31M
Net Income	-1.07M	324.21K	-1.85M	-4.69M
R&D	4.03M	492.46K	128.73K	-
Interest Expense	4.73K	10.00K	2.46K	3.67K

Balance Sheet

Currency: AUD	2023-06-30	2024-06-30	2025-06-30	2026-06-30
Total Assets	5.29M	9.69M	16.96M	15.18M
Total Liabilities	597.36K	85.68K	149.22K	374.89K
Total Equity	4.69M	5.35M	16.81M	14.81M
Cash	4.91M	9.20M	7.27M	2.63M

Cash Flow

Currency: AUD	2023-06-30	2024-06-30	2025-06-30	2026-06-30
Financing Cash Flow	-	0	3.29M	-30.26K
Capital Expenditure	0	1.81K	0	0
Free Cash Flow	-2.30M	42.43K	-941.33K	-2.78M

Key Statistics & Ratios

Market Cap19.49M

Enterprise Value14.94M

Trailing P/E0.00

Forward P/E0.00

Price / Sales48.39

Price / Book1.32

EPS-0.01

Book Value0.038

Revenue (TTM)402.66K

Gross Profit (TTM)258.28K

EBITDA-3.32M

Profit Margin0.00%

Operating Margin-3407.53%

Return on Equity-29.68%

Return on Assets-18.30%

Shares Outstanding389.72M

Shares Float152.64M

Beta1.23

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%